MRI and Outcomes for Early Form of Breast Cancer
Study found that the costly scan didn't lead to less recurrence for ductal carcinoma in situ
WebMD News Archive
By Mary Elizabeth Dallas
WEDNESDAY, Sept. 4 (HealthDay News) -- Adding in pricey MRI scans does not boost outcomes for most women who undergo a lumpectomy for the early, noninvasive form of breast cancer called ductal carcinoma in situ (DCIS), a new study finds.
Some doctors order a routine MRI to look for more cancer or confirm the findings of a physical exam, mammogram or ultrasound. Researchers found, however, that adding an MRI to a mammogram before or right after surgery did not cut DCIS recurrence rates.
"We now have a lot of evidence that indicates that MRI isn't necessary for every patient with DCIS," lead author Dr. Melissa Pilewskie, a breast surgeon at Memorial Sloan-Kettering Cancer Center in New York City, said in a hospital news release. "Aside from the cost of the test, MRI has a rather high false-positive rate, which may result in additional biopsies and a delay in surgery."
Instead, Pilewskie said, "We need to focus on spending money and time on tests that we know are going to provide benefit."
In the study, the researchers analyzed the localized recurrence rates for more than 2,300 women who underwent a lumpectomy (removal of a mass) for DCIS between 1997 and 2010. Of these women, nearly 600 had an MRI either right before or after surgery while the remainder did not.
After a five-year follow-up period, the researchers found no statistically meaningful differences in localized recurrence rates between the two groups of women, even eight years after surgery. This remained true after taking certain risk factors for recurrence into account.
The researchers pointed out that the women who underwent an MRI often were younger, had not gone through menopause and were more likely to have a family history of breast cancer. This could also explain why these women's doctors had ordered an MRI, Pilewskie's team said.
The study also showed that there were no statistically significant differences in rates of contralateral breast cancer -- cancer on the opposite breast -- five years or eight years after surgery between the women who had an MRI and those who only had a mammogram around the time of their lumpectomy.